• Aucun résultat trouvé

Accelerating the elimination of cervical cancer as a global public health problem

N/A
N/A
Protected

Academic year: 2022

Partager "Accelerating the elimination of cervical cancer as a global public health problem"

Copied!
1
0
0

Texte intégral

(1)

EXECUTIVE BOARD EB144(2)

1144th session 30 January 2019

Agenda item 6.5

Accelerating the elimination of cervical cancer as a global public health problem

The Executive Board, having considered the report on accelerating cervical cancer elimination,1 decided:

(1) to note that urgent action is needed to scale up implementation of proven cost-effective measures towards achieving the elimination of cervical cancer as a global public health problem, including vaccination against human papillomavirus, screening and treatment of pre-cancer, early detection and prompt treatment of early invasive cancers and palliative care, which will require political commitment and greater international cooperation and support for equitable access, including strategies for resource mobilization;

(2) to request the Director-General to develop, in consultation with Member States and other relevant stakeholders, a draft global strategy to accelerate cervical cancer elimination, with clear goals and targets for the period 2020–2030, for consideration by the Seventy-third World Health Assembly, through the Executive Board at its 146th session.

Thirteenth meeting, 30 January 2019 EB144/SR/13

= = =

1 Document EB144/28.

Références

Documents relatifs

In November 2020, the World Health Organization (WHO) officially launched the Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem, which

The Action Plan identifies priorities, targets and actions to improve HPV immunization, implement HPV primary screening and improve follow-up of abnormal screening results

In contrast to the strongly performing vaccination programme, the impact of the screening services in Malaysia was low and there was no formal follow up or tracking of women that

assistance to help end cervical cancer deaths would help address this disparity between the causes of death and the priorities of current global health funding.. More than 40

It focuses on the knowledge, best practices and communication skills needed by health-care providers working at community and primary and secondary levels of care to offer

WHO guidance on post-market surveillance of medical devices, including in vitro diagnostic medical devices (IVDs), provides an overview of proactive and reactive measures to

These efforts include the development of global normative guidance (e.g. Saving lives, spending less) 4 and regional commitments and capacity-building (e.g., Regional

Au niveau national, le principal critère pour l’élimination de la THA en tant que problème de santé publique est défini à moins de 1 cas/10 000 habitants/an